A single-center, placebo-controlled study of the effects of ascending single oral doses of aliskiren compared with captopril on renal hemodynamics in healthy volunteers on a low and high sodium diet 'renin inhibition and the kidney'

Trial Profile

A single-center, placebo-controlled study of the effects of ascending single oral doses of aliskiren compared with captopril on renal hemodynamics in healthy volunteers on a low and high sodium diet 'renin inhibition and the kidney'

Completed
Phase of Trial: Phase III

Latest Information Update: 05 Oct 2010

At a glance

  • Drugs Aliskiren; Captopril
  • Indications Acute heart failure; Diabetic macular oedema; Diabetic nephropathies; Heart failure; Hypertension; Myocardial infarction
  • Focus Pharmacodynamics
  • Sponsors Novartis
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 16 Jul 2008 Actual end date is added (August 2007) as reported by ClinicalTrials.gov.
    • 16 Jul 2008 Status changed from in progress to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top